Overall, Liu’s lab showed that prime editors could make all 12 single nucleotide changes, insert new DNA sequences up to 44 nucleotides long, and delete sequences up to 80 base pairs long.

Scientist and biotech cofounder David Liu is one of the pioneers of drugs that can edit DNA. His lab is developing therapy that could prevent Alzheimer's by installing a protective gene. Liu was ...

Liu’s prolific career over the past two decades has won him several prestigious distinctions. In 2017, he was named one of Nature’s Top 10 researchers in the world.

Brandeis University has named David R. Liu, an internationally recognized chemical biologist, as the 26th Jacob and Louise Gabbay Award recipient for his pioneering research in gene editing, which has ...

Matt Fuchs lives in Maryland and writes about health, science, and technology. Courtesy Liu In 2021, David Liu couldn’t sleep after the U.S. Food and Drug Administration cleared the first ...

A new type of DNA editing enzyme, developed in HHMI Investigator David Liu’s lab, lets scientists directly and permanently change single base pairs of DNA from A•T to G•C. The process could one day ...

Three startups launch, and David Liu has co-founded another gene-editing startup. More in the Petri Dish. Related Articles . Genentech signs $2.5B+ deal with Waltham biotech ...

David Liu, the inventor of base editing and prime editing, has been awarded the 2025 Breakthrough Prize in Life Sciences. Casey Atkins. While researchers have long appreciated the enormous potential ...

By contrast, base editing technology, first disclosed in 2016 by Liu’s lab—is under investigation in six ongoing clinical trials. Prime Medicine has not yet released which of its 18 pipeline ...

In an exemplary keynote address by David Liu, the developer of base and prime editing salutes the rapid uptake of “CRISPR 2.0” editing technologies around the world, as indicated by a ...